Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes and obesity. It works as a GLP-1 agonist, increasing insulin secretion and improving blood sugar control. By slowing down digestion, semaglutide helps patients feel full and reduces the urge to eat. However, it is currently only approved for individuals with a BMI greater than 30 or those with a BMI greater than 27 and one weight-related comorbidity. At Omni Health and Wellness we are able to treat Patient to a BMI of 19.
The big takeaways:
A: Common side effects of semaglutide include nausea, diarrhea, vomiting, constipation, and abdominal pain.
A: Studies have shown an average weight loss of about 20% over 72 weeks with Tirzepatide.
A: Early data suggests a potential weight loss of 24% with Retatrutide.
A: Combining peptide therapy with these medications and optimizing testosterone levels can help prevent muscle loss.
A: Injection-based supplementation is recommended for optimizing vitamin D and B12 levels.